Supernus Pharmaceuticals, Inc. (SUPN)
50.69
-0.17
(-0.33%)
USD |
NASDAQ |
Feb 23, 16:00
50.41
-0.28
(-0.55%)
Pre-Market: 08:04
Supernus Pharmaceuticals Price : 50.69 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 196.34 |
| Catalyst Pharmaceuticals, Inc. | 24.11 |
| Oncotelic Therapeutics, Inc. | 0.045 |
| Vertex Pharmaceuticals, Inc. | 481.01 |
| Krystal Biotech, Inc. | 274.59 |
Price Related Metrics
| PS Ratio | 4.193 |
| Price to Book Value | 2.769 |
| Price to Free Cash Flow | 40.39 |
| Earnings Yield | -0.67% |
| Market Cap | 2.907B |